SCHEMBL7599042

SCHEMBL7599042

CCOCCNc1ccc(/C(=C(/CC)Cc2ccccc2)c2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.43
CYP19A1 P11511 3/20 0.40
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
RAB9A P51151 3/20 0.37
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
NPC1 O15118 2/20 0.36
HDAC3 O15379 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC2 Q92769 2/20 0.36
NCOR2 Q9Y618 1/20 0.36
NAMPT P43490 1/20 0.35
PTGS2 P35354 1/20 0.35
HPGD P15428 1/20 0.35
GAA P10253 1/20 0.35
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7599046 1.00 ESR1 (0.43) ESR1CYP19A1CA1CA2SMN1; SMN2
SCHEMBL7596104 0.93 SMN1; SMN2 (0.43) ESR1CYP19A1CA1CA2SMN1; SMN2
SCHEMBL7598596 0.93 SMN1; SMN2 (0.43) ESR1CYP19A1CA1CA2SMN1; SMN2
SCHEMBL7600809 0.91 ESR1 (0.43) ESR1CYP19A1CA1CA2SMN1; SMN2
SCHEMBL7602304 0.91 ESR1 (0.43) ESR1CYP19A1CA1CA2SMN1; SMN2
SCHEMBL7598327 0.89 ESR1 (0.44) ESR1CYP19A1CA1CA2SMN1; SMN2
SCHEMBL7599310 0.89 ESR1 (0.44) ESR1CYP19A1CA1CA2SMN1; SMN2
SCHEMBL7602281 0.84 ESR1 (0.41) ESR1CYP19A1CA1CA2SMN1; SMN2
SCHEMBL7602285 0.84 ESR1 (0.41) ESR1CYP19A1CA1CA2SMN1; SMN2
SCHEMBL7598079 0.84 ESR1 (0.43) ESR1CYP19A1CA1CA2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020161007-A1 Non-steroidal modulators of estrogen receptors PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161007-A1 Non-steroidal modulators of estrogen receptors ESRRB, ESR2, ESRRG ESR1 6/4885CYP19A1 13/4885CA1 1562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.